BioSpace News Archive

BioMidwest

Metastatic Tumor Treatment with Novel GPX Embolic Device

As part of an ongoing multi-center study, Fluidx Medical released additional information on treating tumors including a highly vascularized metastatic renal cell carcinoma with the GPX Embolic Device.

March 9, 2022
·
1 min read
Compugen to Present at the Oppenheimer 32nd Annual Global Healthcare Conference

Compugen Ltd. today announced that management will present at the Oppenheimer 32nd Annual Global Healthcare Conference (virtual), on Wednesday, March 16, 2022 at 11:20 am ET .

March 9, 2022
·
2 min read
BioCapital

REGENXBIO to Participate in Upcoming Investor Conferences in March 2022

REGENXBIO Inc. announced it will participate in the following upcoming investor conferences.

March 9, 2022
·
1 min read
Pharm Country

Bayer Submits Applications in the U.S. and EU for Additional Indication of NUBEQA® (darolutamide)

Bayer Submits Applications in the U.S. and EU for Additional Indication of NUBEQA ® (darolutamide).

March 9, 2022
·
11 min read
Business

Protara Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Business Overview

Protara Therapeutics, Inc. today announced financial results for the fourth quarter and year ended December 31, 2021.

March 9, 2022
·
12 min read
Pharm Country

Akari Therapeutics Announces New Data Supporting Use of Drug Candidate Votucalis Targeting Difficult to Treat Pain and Itch

Akari Therapeutics, Plc today announced new preclinical data published in Frontiers in Pharmacology demonstrating that Akari’s pipeline candidate votucalis has potential as a treatment for pain and itch associated with conditions such as atopic dermatitis, psoriasis and neuropathic pain.

March 9, 2022
·
6 min read
Business

Tataa Biocenter is partnering with Olink and Illumina to offer high performance proteomics with unprecedented throughput

Tataa Biocenter AB, a leading European provider of molecular analysis services with ISO 17025 accreditation, is launching Olink® EXPLORE 3072 proteome profiling service.

March 9, 2022
·
3 min read
Genetown

Ultivue Announces Co-Marketing Agreement with Aignostics for Unique Spatial AI-Powered Imaging Solutions for Translational Medicine

Ultivue, Inc. and Aignostics GmbH announced a partnership to collaborate on the co-development of AI-powered spatial multiplexed immunophenotype solutions for translational research groups and Biopharma.

March 9, 2022
·
3 min read
Biotech Bay

Bristol Myers Squibb to Participate in Upcoming Investor Conferences on March 16

Bristol Myers Squibb announced its participation in the following investor conferences on Wednesday, March 16, 2022:

March 9, 2022
·
1 min read
Biotech Bay

GT Biopharma Presented Preclinical Data Demonstrating Novel Mesothelin-Targeted TriKE® Driving Cytotoxicity Across All Stages of Non-Small Cell Lung Cancer at ESMO TAT 2022

GT Biopharma, Inc. (NASDAQ: GTBP), presented preclinical data demonstrating its novel TriKE driving NK cell immunotherapy against non-small cell lung cancer (NSCLC) in the hypoxic solid tumor microenvironment at ESMO’s Targeted Anticancer Therapies Congress (TAT).

March 9, 2022
·
6 min read